Summary
Synlait Milk has appointed Leon Fung as permanent chief executive after five months in the interim role, a move the dairy nutritionals processor said would provide continuity for its financial recovery and strategic restructuring. Fung brings more than 30 years of experience in dairy processing, food technology and commercial management across Australia, New Zealand and Greater China, having previously held senior roles at Yashili's Pokeno nutritional powder plant, Nutricia's infant formula manufacturing operations, Danone New Zealand and NiG Nutritionals. The company reported improved performance in its specialised ingredients business in the latter part of FY2026, including medicinal-grade lactoferrin, adult nutritional powders and clinical products, and is reviewing its infant formula manufacturing arrangements for supply to China in response to updated registration requirements and demographic change in East Asia.
Maintaining its farmer supplier base is another part of the recovery plan, with Synlait relying on contract milk from Canterbury and Waikato and supporting retention through base price advances, incentive payments linked to its Lead with Pride sustainability certification and prompt settlement. Earlier operational uncertainty had raised concerns about retaining South Island milk supply, and the company is linking processing efficiency improvements to supplier payment commitments to protect milk volumes and plant utilisation.
Commentary
Synlait's formal appointment of Leon Fung as chief executive signals the Canterbury dairy company's push for stable leadership after a period of financial turbulence. Fung's track record at Danone and Yashili, particularly his Greater China experience, is critical for Synlait: China was once its key market, but new infant formula registration rules and falling birth rates have forced the company to review its supply arrangements to China. The shift toward higher-value specialised ingredients such as medicinal-grade lactoferrin and adult nutritional powders is a pragmatic move to reduce reliance on a single category, but it also means intensifying competition with giants such as Fonterra in high-end ingredients.
For New Zealand small and medium-sized enterprises, Synlait's transformation highlights the trend of dairy exports upgrading from commodities to functional and clinical products, which could generate new demand for equipment, testing and logistics providers. At the same time, Synlait's use of advance payments and sustainability incentives to retain farmers reflects fierce competition for raw milk supply, and SMEs need to watch the flexibility of contract terms to safeguard their own supply chains.
Keywords: Synlait, Leon Fung, CEO appointment, dairy nutritionals processing, infant formula, lactoferrin, farmer suppliers, financial recovery
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.
